Retroperitoneal Lymphadenectomy

Specimen Sites:

Size of Largest Metastasis:
Not applicable
Greatest dimension (cm):

Prelymphadenectomy Treatment:
Chemo/radiation therapy
No chemo/radiation therapy
Unknown

Serum Tumor Markers:
   Unknown
   Serum marker studies within normal limits
   Alpha-fetoprotein (AFP) elevation: U/L (Reference (135-225) U/L)
   Beta subunit of HCG (b-hCG) elevation: mIU/ml (Reference (<2) mIU/mL)
   Lactate dehydrogenase (LDH) elevation: U/L (Reference (135-225) U/L)

Viability of Tumor:
Viable teratoma present
Viable non-teratomatous tumor present
No viable tumor present

Histologic Type of Metastatic Tumor:
Seminoma, classic type
Seminoma with syncytiotrophoblastic cells
Mixed germ cell tumor(specify components and percentages):
Embryonal carcinoma
Yolk sac tumor
Choriocarcinoma, biphasic
Choriocarcinoma, monophasic
Placental site trophoblastic tumor
Mature teratoma
Immature teratoma
Teratoma with a secondary malignant component(specify type):
Monodermal teratoma, carcinoid
Monodermal teratoma, primitive neuroectodermal tumor
Polyembryoma
Diffuse embryoma
Spermatocytic seminoma
Spermatocytic seminoma with a sarcomatous component
Other (specify):
Malignant neoplasm, type cannot be determined

Previous radiation or chemotherapy (yp)

Regional Lymph Nodes (pN):
pNX: Cannot be assessed
pN0: No regional lymph node metastasis ( 0 / )
pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none greater than 2 cm in greatest dimension ( / )
pN2: Metastasis with a lymph node mass greater than 2 cm but no more than 5 cm in greatest dimension, or more than 5 nodes positive, none greater than 5 cm; or evidence of extranodal extension of tumor ( / )
pN3: Metastasis in a lymph node greater than 5 cm in greatest dimension ( / )

Nonregional Lymph Node Metastasis (M1a):
Not applicable
Absent
Present